{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:02:30Z","timestamp":1792958550473,"version":"4.5.0"},"reference-count":436,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J1-1710"],"award-info":[{"award-number":["J1-1710"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["N1-0127"],"award-info":[{"award-number":["N1-0127"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0140"],"award-info":[{"award-number":["P1-0140"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.mam.2022.101150","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:17:45Z","timestamp":1666444665000},"page":"101150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Cysteine cathepsins: A long and winding road towards clinics"],"prefix":"10.1016","volume":"88","author":[{"given":"Monika","family":"Biasizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Javor\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Vidak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Zari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-5764","authenticated-orcid":false,"given":"Boris","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1074\/jbc.M117.814772","article-title":"Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis","volume":"293","author":"Aghdassi","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.mam.2022.101150_bib2","doi-asserted-by":"crossref","first-page":"E2748","DOI":"10.1073\/pnas.1620954114","article-title":"Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36gamma","volume":"114","author":"Ainscough","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.mam.2022.101150_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239140","article-title":"Procathepsin V is secreted in a TSH regulated manner from human thyroid epithelial cells and is accessible to an activity-based probe","volume":"21","author":"Al-Hashimi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajhg.2013.06.002","article-title":"Mutations in LRPAP1 are associated with severe myopia in humans","volume":"93","author":"Aldahmesh","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1074\/jbc.M003820200","article-title":"Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation","volume":"276","author":"Almeida","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BCJ20190847","article-title":"Characterization of cathepsin S exosites that govern its elastolytic activity","volume":"477","author":"Andrault","year":"2020","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ajg.2013.152","article-title":"Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS","volume":"108","author":"Annahazi","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"5863","key":"10.1016\/j.mam.2022.101150_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.1150110","article-title":"Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis","volume":"319","author":"Asagiri","year":"2008","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.mam.2022.101150_bib9","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.febslet.2005.06.066","article-title":"Endosomal proteolysis of insulin-like growth factor-I at its C-terminal D-domain by cathepsin B","volume":"579","author":"Authier","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2017.11.015","article-title":"Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome","volume":"362","author":"Bai","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"6 Suppl. 2","key":"10.1016\/j.mam.2022.101150_bib11","first-page":"24","article-title":"Cathepsin B in osteoarthritis: uncontrolled proteolysis in the wrong place","volume":"34","author":"Baici","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib12","first-page":"2","article-title":"Pathophysiology of acute and infected pancreatitis","volume":"10","author":"Bakoyiannis","year":"2010","journal-title":"Infect. Disord.: Drug Targets"},{"key":"10.1016\/j.mam.2022.101150_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128202","article-title":"Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy","volume":"47","author":"Banerjee","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2006.11.017","article-title":"Role of the cysteine protease cathepsin S in neuropathic hyperalgesia","volume":"130","author":"Barclay","year":"2007","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib16","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1128\/AAC.49.12.5160-5161.2005","article-title":"A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi","volume":"49","author":"Barr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.sjbs.2021.09.014","article-title":"Exploring the role of cathepsin in rheumatoid arthritis","volume":"29","author":"Behl","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.mam.2022.101150_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-015-0586-5","article-title":"Detecting cathepsin activity in human osteoarthritis via activity-based probes","volume":"17","author":"Ben-Aderet","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mam.2022.101150_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2016.11.028","article-title":"Cathepsin nanofiber substrates as potential agents for targeted drug delivery","volume":"257","author":"Ben-Nun","year":"2017","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/mc.22312","article-title":"Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis","volume":"55","author":"Bian","year":"2016","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib22","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1021\/pr200621z","article-title":"Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S","volume":"10","author":"Biniossek","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mam.2022.101150_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","article-title":"The acidic tumor microenvironment as a driver of cancer","volume":"82","author":"Boedtkjer","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11255-020-02602-y","article-title":"Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients","volume":"53","author":"Bolignano","year":"2021","journal-title":"Int. Urol. Nephrol."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/pro.4073","article-title":"Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V","volume":"30","author":"Bollavaram","year":"2021","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11914-011-0085-9","article-title":"Inhibition of cathepsin K for treatment of osteoporosis","volume":"10","author":"Boonen","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"issue":"17","key":"10.1016\/j.mam.2022.101150_bib27","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.mam.2022.101150_bib28","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1089\/neu.2019.6537","article-title":"Penetrating traumatic brain injury triggers dysregulation of cathepsin B protein levels independent of cysteine protease activity in brain and cerebral spinal fluid","volume":"37","author":"Boutte","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.mam.2022.101150_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biochi.2019.05.018","article-title":"Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery","volume":"166","author":"Bratovs","year":"2019","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106119","article-title":"In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection","volume":"56","author":"Braz","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biochi.2007.07.024","article-title":"Cysteine cathepsins: cellular roadmap to different functions","volume":"90","author":"Brix","year":"2008","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1515\/bchm.2001.382.5.717","article-title":"Cysteine proteinases mediate extracellular prohormone processing in the thyroid","volume":"382","author":"Brix","year":"2001","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/13543780902832661","article-title":"Cathepsin K inhibitors for osteoporosis and potential off-target effects","volume":"18","author":"Bromme","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib35","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bi982175f","article-title":"Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization","volume":"38","author":"Bromme","year":"1999","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/17460441.2016.1160884","article-title":"Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: commonalities and differences","volume":"11","author":"Bromme","year":"2016","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.mam.2022.101150_bib37","series-title":"Extracellular Matrix Degradation","first-page":"23","article-title":"Role of cysteine cathepsins in extracellular proteolysis","author":"Br\u00f6mme","year":"2011"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib38","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0002-9440(10)63777-7","article-title":"Pivotal role of cathepsin K in lung fibrosis","volume":"164","author":"B\u00fchling","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.mam.2022.101150_bib39","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1158\/1078-0432.CCR-09-1262","article-title":"Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis","volume":"15","author":"Burden","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biochi.2011.08.017","article-title":"Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas","volume":"94","author":"Burden","year":"2012","journal-title":"Biochimie"},{"issue":"11\u201312","key":"10.1016\/j.mam.2022.101150_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejcb.2007.03.009","article-title":"Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes","volume":"86","author":"Buth","year":"2007","journal-title":"Eur. J. Cell Biol."},{"issue":"11\u201312","key":"10.1016\/j.mam.2022.101150_bib42","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1078\/0171-9335-00428","article-title":"HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration","volume":"83","author":"Buth","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"15","key":"10.1016\/j.mam.2022.101150_bib43","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"24","key":"10.1016\/j.mam.2022.101150_bib44","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-17-2391","article-title":"Cathepsin B is dispensable for cellular processing of cathepsin B-cleavable antibody-drug conjugates","volume":"77","author":"Caculitan","year":"2017","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.mam.2022.101150_bib45","doi-asserted-by":"crossref","first-page":"33076","DOI":"10.1074\/jbc.M705761200","article-title":"Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions","volume":"282","author":"Caglic","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/hsz-2012-0283","article-title":"The proinflammatory cytokines interleukin-1alpha and tumor necrosis factor alpha promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes","volume":"394","author":"Caglic","year":"2013","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(21)00139-X","article-title":"Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial","volume":"22","author":"Caimi","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2008.06.021","article-title":"Sortilin mediates the lysosomal targeting of cathepsins D and H","volume":"373","author":"Canuel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152583","article-title":"Plasma membrane repair is regulated extracellularly by proteases released from lysosomes","volume":"11","author":"Castro-Gomes","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib51","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1073\/pnas.87.10.3861","article-title":"Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain","volume":"87","author":"Cataldo","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib52","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.07.035","article-title":"Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice","volume":"141","author":"Cattaruzza","year":"2011","journal-title":"Gastroenterology"},{"issue":"Pt 7","key":"10.1016\/j.mam.2022.101150_bib53","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1242\/jcs.02278","article-title":"Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells","volume":"118","author":"Cavallo-Medved","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mam.2022.101150_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0070-2153(03)54013-3","article-title":"Cell-surface cathepsin B: understanding its functional significance","volume":"54","author":"Cavallo-Medved","year":"2003","journal-title":"Curr. Top. Dev. Biol."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib55","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-08-4539","article-title":"VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation","volume":"69","author":"Chang","year":"2009","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib56","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1021\/nn302972r","article-title":"(alpha-NaYbF4:Tm(3+))\/CaF2 core\/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging","volume":"6","author":"Chen","year":"2012","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cvr\/cvt158","article-title":"Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction","volume":"100","author":"Chen","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/hmg\/ddl474","article-title":"Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence","volume":"16","author":"Chen","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"16","key":"10.1016\/j.mam.2022.101150_bib59","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"issue":"29","key":"10.1016\/j.mam.2022.101150_bib60","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1021\/acsami.5b04517","article-title":"Activable cell-penetrating peptide conjugated prodrug for tumor targeted drug delivery","volume":"7","author":"Cheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2013.01.004","article-title":"Circulating cathepsin K as a potential novel biomarker of coronary artery disease","volume":"228","author":"Cheng","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2353\/ajpath.2006.050295","article-title":"Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3","volume":"168","author":"Cheng","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib63","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","article-title":"Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.mam.2022.101150_bib64","doi-asserted-by":"crossref","first-page":"12824","DOI":"10.1074\/jbc.M513331200","article-title":"Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities","volume":"281","author":"Choe","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2022.101150_bib65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13104-015-1284-8","article-title":"Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K","volume":"8","author":"Christensen","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.mam.2022.101150_bib66","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biocel.2014.07.018","article-title":"Interleukin-1beta promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca(2)(+)-dependent activation of ERK","volume":"54","author":"Chung","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib67","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1074\/jbc.M308347200","article-title":"Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins","volume":"279","author":"Cirman","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib68","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/art.34351","article-title":"Spinal cathepsin S and fractalkine contribute to chronic pain in the collagen-induced arthritis model","volume":"64","author":"Clark","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"14","key":"10.1016\/j.mam.2022.101150_bib69","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.21042","article-title":"Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor","volume":"58","author":"Clark","year":"2010","journal-title":"Glia"},{"issue":"25","key":"10.1016\/j.mam.2022.101150_bib70","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1073\/pnas.0610811104","article-title":"Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain","volume":"104","author":"Clark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.mam.2022.101150_bib71","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1523\/JNEUROSCI.0828-09.2009","article-title":"The liberation of fractalkine in the dorsal horn requires microglial cathepsin S","volume":"29","author":"Clark","year":"2009","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(21)00056-5","article-title":"Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204\/GOG-3023\/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study","volume":"22","author":"Coleman","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2022.101150_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(04)41001-8","article-title":"Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L","volume":"241","author":"Collette","year":"2004","journal-title":"Int. Rev. Cytol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7326\/M19-0675","article-title":"Disease-modifying effects of a novel cathepsin K inhibitor in osteoarthritis: a randomized controlled trial","volume":"172","author":"Conaghan","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib75","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.joca.2009.03.015","article-title":"Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis","volume":"17","author":"Connor","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV hodgkin's lymphoma","volume":"378","author":"Connors","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cellimm.2010.11.004","article-title":"Cytokines regulate cysteine cathepsins during TLR responses","volume":"267","author":"Creasy","year":"2011","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jocd.2018.05.039","article-title":"A prospective assessment of periprosthetic bone mineral density and osteoimmunological biomarkers variations after total knee replacement surgery","volume":"22","author":"Cucchi","year":"2019","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12872-021-02040-3","article-title":"Significances of viable synergistic autophagy-associated cathepsin B and cathepsin D (CTSB\/CTSD) as potential biomarkers for sudden cardiac death","volume":"21","author":"Dai","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib80","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/acs.bioconjchem.7b00304","article-title":"Protease-cleavable linkers modulate the anticancer activity of noninternalizing antibody-drug conjugates","volume":"28","author":"Dal Corso","year":"2017","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib81","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1038\/s41598-019-39502-w","article-title":"Deep-tissue optical imaging of near cellular-sized features","volume":"9","author":"Dang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2022.101150_bib82","article-title":"Cathepsin B launches an apoptotic exit effort upon cell death-associated disruption of lysosomes","volume":"2","author":"de Castro","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib83","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1038\/s41598-019-40040-8","article-title":"Long-term exercise training improves memory in middle-aged men and modulates peripheral levels of BDNF and Cathepsin B","volume":"9","author":"De la Rosa","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib84","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/onc.2009.466","article-title":"Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis","volume":"29","author":"Dennemarker","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib85","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.1038\/s41598-019-46068-0","article-title":"Cathepsin Z as a novel potential biomarker for osteoporosis","volume":"9","author":"Dera","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mol.107.039511","article-title":"Effect of cathepsin k inhibitor basicity on in vivo off-target activities","volume":"73","author":"Desmarais","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"207","key":"10.1016\/j.mam.2022.101150_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006682","article-title":"Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index","volume":"5","author":"Desnoyers","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2022.101150_bib88","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.addr.2019.01.010","article-title":"Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases","volume":"151\u2013152","author":"Dheer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.mam.2022.101150_bib89","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s40265-018-1000-9","article-title":"Moxetumomab pasudotox: first global approval","volume":"78","author":"Dhillon","year":"2018","journal-title":"Drugs"},{"issue":"19","key":"10.1016\/j.mam.2022.101150_bib90","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1212\/WNL.0000000000000953","article-title":"Pseudo-dominant inheritance of a novel CTSF mutation associated with type B Kufs disease","volume":"83","author":"Di Fabio","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib92","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S","article-title":"Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues","volume":"42","author":"Dodds","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib93","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ajpath.2017.04.014","article-title":"Cathepsin K in lymphangioleiomyomatosis: LAM cell-fibroblast interactions enhance protease activity by extracellular acidification","volume":"187","author":"Dongre","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"20","key":"10.1016\/j.mam.2022.101150_bib94","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/acs.jmedchem.6b01127","article-title":"Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)","volume":"59","author":"Doyle","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib95","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrd3053","article-title":"Emerging principles in protease-based drug discovery","volume":"9","author":"Drag","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","article-title":"Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned","volume":"38","author":"Drake","year":"2017","journal-title":"Endocr. Rev."},{"issue":"27","key":"10.1016\/j.mam.2022.101150_bib97","doi-asserted-by":"crossref","first-page":"19140","DOI":"10.1074\/jbc.M802513200","article-title":"Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues","volume":"283","author":"Droga-Mazovec","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.mam.2022.101150_bib98","doi-asserted-by":"crossref","first-page":"34871","DOI":"10.1074\/jbc.M113.510008","article-title":"Elastin degradation by cathepsin V requires two exosites","volume":"288","author":"Du","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib99","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/bc025536j","article-title":"Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity","volume":"13","author":"Dubowchik","year":"2002","journal-title":"Bioconjugate Chem."},{"issue":"7293","key":"10.1016\/j.mam.2022.101150_bib100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cell.2008.09.055","article-title":"Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation","volume":"135","author":"Duncan","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib102","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0950-3536(97)80041-8","article-title":"Skeletal involvement in Gaucher's disease","volume":"10","author":"Elstein","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib103","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.1780370213","article-title":"Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis","volume":"37","author":"Esser","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib104","first-page":"1176","article-title":"The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis","volume":"20","author":"Esser","year":"1993","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib105","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1470-2045(21)00094-2","article-title":"Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial","volume":"22","author":"Evan","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib106","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbrc.2007.12.062","article-title":"A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation","volume":"366","author":"Fairhead","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"80","key":"10.1016\/j.mam.2022.101150_bib107","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1039\/C8CC05982A","article-title":"Increasing time on target: utilization of inhibitors of cysteine cathepsins to enhance the tumor retention of receptor-targeted agents","volume":"54","author":"Fan","year":"2018","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.mam.2022.101150_bib108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejmech.2019.05.068","article-title":"Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor","volume":"177","author":"Fan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mam.2022.101150_bib109","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2018.11.010","article-title":"Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction","volume":"127","author":"Fang","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151678","article-title":"Biomechanical and histological characterization of MPS I mice femurs","volume":"123","author":"Ferreira","year":"2021","journal-title":"Acta Histochem."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib111","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1998.16.3.1013","article-title":"Prognostic significance of cathepsins B and L in primary human breast cancer","volume":"16","author":"Foekens","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mam.2022.101150_bib112","first-page":"1017","article-title":"Osteoporosis: pathophysiology and therapeutic options","volume":"19","author":"Foger-Samwald","year":"2020","journal-title":"EXCLI J"},{"issue":"5\u20136","key":"10.1016\/j.mam.2022.101150_bib113","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.201300085","article-title":"Cysteine cathepsins and their potential in clinical therapy and biomarker discovery","volume":"8","author":"Fonovic","year":"2014","journal-title":"Proteonomics Clin. Appl."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib114","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1515\/hsz-2013-0189","article-title":"Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells","volume":"394","author":"Fonovic","year":"2013","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib115","first-page":"30","article-title":"Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes","volume":"21","author":"Fujimoto","year":"2021","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib116","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000503","article-title":"Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker","volume":"2","author":"Fujita","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib117","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/jm401705g","article-title":"Cathepsin C inhibitors: property optimization and identification of a clinical candidate","volume":"57","author":"Furber","year":"2014","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib118","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acs.nanolett.7b03813","article-title":"Molecular imaging of cancer using X-ray computed tomography with protease targeted iodinated activity-based probes","volume":"18","author":"Gaikwad","year":"2018","journal-title":"Nano Lett."},{"issue":"80","key":"10.1016\/j.mam.2022.101150_bib119","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1039\/C5CC06207A","article-title":"Enzyme-responsive pillar[5]arene-based polymer-substituted amphiphiles: synthesis, self-assembly in water, and application in controlled drug release","volume":"51","author":"Gao","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.mam.2022.101150_bib120","doi-asserted-by":"crossref","first-page":"v140","DOI":"10.1093\/annonc\/mdx367.055","article-title":"PROCLAIM-CX-2009: a first-in-human trial to evaluate CX-2009 in adults with metastatic or locally advanced unresectable solid tumors","volume":"28","author":"Garcia-Corbacho","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib121","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.chembiol.2015.12.003","article-title":"A bright future for precision medicine: advances in fluorescent chemical probe design and their clinical application","volume":"23","author":"Garland","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib122","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","article-title":"Staphylococcus aureus: new evidence for intracellular persistence","volume":"17","author":"Garzoni","year":"2009","journal-title":"Trends Microbiol."},{"issue":"5279","key":"10.1016\/j.mam.2022.101150_bib123","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","article-title":"Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency","volume":"273","author":"Gelb","year":"1996","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib124","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","article-title":"Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression","volume":"424","author":"Gnirss","year":"2012","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/cc.6.1.3669","article-title":"Cysteine cathepsins and the cutting edge of cancer invasion","volume":"6","author":"Gocheva","year":"2007","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1101\/gad.1407406","article-title":"Distinct roles for cysteine cathepsin genes in multistage tumorigenesis","volume":"20","author":"Gocheva","year":"2006","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib128","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1515\/BC.2008.109","article-title":"Regulation of cathepsin K activity by hydrogen peroxide","volume":"389","author":"Godat","year":"2008","journal-title":"Biol. Chem."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/01902140902822304","article-title":"Role for cathepsin K in emphysema in smoke-exposed Guinea pigs","volume":"35","author":"Golovatch","year":"2009","journal-title":"Exp. Lung Res."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/gutjnl-2011-300850","article-title":"Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice","volume":"61","author":"Gopinathan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.mam.2022.101150_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105213","article-title":"Synthesis and kinetic characterization of hyperbolic inhibitors of human cathepsins K and S based on a succinimide scaffold","volume":"115","author":"Gorican","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib132","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1097-2765(04)00209-6","article-title":"A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP\/Cux transcription factor","volume":"14","author":"Goulet","year":"2004","journal-title":"Mol. Cell."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib133","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1158\/1541-7786.MCR-07-0160","article-title":"Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation","volume":"5","author":"Goulet","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib134","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.mam.2022.101150_bib135","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/S0021-9258(18)69688-7","article-title":"The activation of trypsinogen by cathepsin B","volume":"234","author":"Greenbaum","year":"1959","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib136","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0969-2126(98)00007-0","article-title":"Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function","volume":"6","author":"Guncar","year":"1998","journal-title":"Structure"},{"issue":"17","key":"10.1016\/j.mam.2022.101150_bib138","doi-asserted-by":"crossref","first-page":"14829","DOI":"10.1074\/jbc.M108180200","article-title":"Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B","volume":"277","author":"Guo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2022.101150_bib139","series-title":"1154-P: Genetic and Pharmacological Suppression of Cathepsin K Promotes Wound Healing in Diabetic Mice","author":"Guo","year":"2019"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI9411","article-title":"Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis","volume":"106","author":"Halangk","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib141","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.ATV.0000063614.21233.BF","article-title":"Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis","volume":"23","author":"Han","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib142","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-019-1955-2","article-title":"Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjogren syndrome","volume":"21","author":"Hargreaves","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mam.2022.101150_bib143","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1038\/srep06081","article-title":"In vivo magnetic resonance imaging of tumor protease activity","volume":"4","author":"Haris","year":"2014","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib144","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.36.12.881","article-title":"Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome","volume":"36","author":"Hart","year":"1999","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145067","article-title":"An active 32-kDa cathepsin L is secreted directly from HT 1080 fibrosarcoma cells and not via lysosomal exocytosis","volume":"10","author":"Hashimoto","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib146","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bone.2012.03.025","article-title":"Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis","volume":"50","author":"Hayami","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.mam.2022.101150_bib147","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/srep02744","article-title":"The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S","volume":"3","author":"Hayashi","year":"2013","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib148","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.joca.2019.01.001","article-title":"Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis","volume":"27","author":"He","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib149","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S1470-2045(19)30317-1","article-title":"Latest developments in molecular tracers for fluorescence image-guided cancer surgery","volume":"20","author":"Hernot","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.116.232926","article-title":"Selective cathepsin S inhibition with MIV-247 attenuates mechanical allodynia and enhances the antiallodynic effects of gabapentin and pregabalin in a mouse model of neuropathic pain","volume":"358","author":"Hewitt","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mam.2022.101150_bib151","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fneur.2015.00178","article-title":"Cathepsin B is a new drug target for traumatic brain injury therapeutics: evidence for E64d as a promising lead drug candidate","volume":"6","author":"Hook","year":"2015","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140428","article-title":"Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders","volume":"1868","author":"Hook","year":"2020","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib153","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/art.10114","article-title":"Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium","volume":"46","author":"Hou","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib154","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1515\/BC.2003.100","article-title":"Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation","volume":"384","author":"Hou","year":"2003","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","article-title":"Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis","volume":"15","author":"Hou","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mam.2022.101150_bib156","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.0105-2896.2005.00310.x","article-title":"The lysosomal cysteine proteases in MHC class II antigen presentation","volume":"207","author":"Hsing","year":"2005","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib157","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib158","first-page":"1887","article-title":"Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction","volume":"25","author":"Hummel","year":"1998","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib159","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/jaut.2001.0580","article-title":"Gene-expression profile of collagen-induced arthritis","volume":"18","author":"Ibrahim","year":"2002","journal-title":"J. Autoimmun."},{"issue":"19","key":"10.1016\/j.mam.2022.101150_bib160","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1016\/j.bmcl.2008.08.067","article-title":"Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2","volume":"18","author":"Irie","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib161","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1006\/bbrc.1995.2820","article-title":"Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro","volume":"217","author":"Ishidoh","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib162","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780400316","article-title":"Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis","volume":"40","author":"Iwata","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mam.2022.101150_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib164","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.prp.2014.08.014","article-title":"Characterization of cathepsin X in colorectal cancer development and progression","volume":"210","author":"Jechorek","year":"2014","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1167\/iovs.14-14850","article-title":"Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 families with early-onset high myopia by exome sequencing","volume":"56","author":"Jiang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib166","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1074\/jbc.RA118.004376","article-title":"Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin","volume":"294","author":"John","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.mam.2022.101150_bib167","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-21-0194","article-title":"Phase I, first-in-human study of the probody therapeutic CX-2029 in adults with advanced solid tumor malignancies","volume":"27","author":"Johnson","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2022.101150_bib168","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2091-10-23","article-title":"Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions","volume":"10","author":"Jordans","year":"2009","journal-title":"BMC Biochem."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib169","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1535-6108(04)00111-4","article-title":"Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis","volume":"5","author":"Joyce","year":"2004","journal-title":"Cancer Cell"},{"issue":"Pt 3","key":"10.1016\/j.mam.2022.101150_bib170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj3310727","article-title":"Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix","volume":"331","author":"Kafienah","year":"1998","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib171","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/40.3.247","article-title":"Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis","volume":"40","author":"Kaneko","year":"2001","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib172","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12931-016-0432-6","article-title":"Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis","volume":"17","author":"Kasabova","year":"2016","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib173","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12890-017-0455-x","article-title":"Cathepsin-S degraded decorin are elevated in fibrotic lung disorders - development and biological validation of a new serum biomarker","volume":"17","author":"Kehlet","year":"2017","journal-title":"BMC Pulm. Med."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib174","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/febs.13980","article-title":"Inherited diseases caused by mutations in cathepsin protease genes","volume":"284","author":"Ketterer","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.mam.2022.101150_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2019.02.003","article-title":"Cathepsins: potent regulators in carcinogenesis","volume":"198","author":"Khaket","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib176","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/bj2640467","article-title":"Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins","volume":"264","author":"Kirschke","year":"1989","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib177","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/rheumatology\/keh395","article-title":"Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis","volume":"43","author":"Kishimoto","year":"2004","journal-title":"Rheumatology"},{"issue":"15","key":"10.1016\/j.mam.2022.101150_bib178","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.107.688523","article-title":"Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice","volume":"115","author":"Kitamoto","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib179","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2004.09.020","article-title":"Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL\/OPG ratio","volume":"36","author":"Kiviranta","year":"2005","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib180","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1359\/jbmr.2001.16.8.1444","article-title":"Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K","volume":"16","author":"Kiviranta","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib181","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1517\/13543784.2015.1099627","article-title":"Discontinued neuropathic pain therapy between 2009-2015","volume":"24","author":"Knezevic","year":"2015","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib182","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-4889(93)90109-3","article-title":"Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes","volume":"1178","author":"Kobayashi","year":"1993","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib183","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1016\/S0021-9258(19)67767-7","article-title":"Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)","volume":"266","author":"Kobayashi","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib184","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/1756-185X.13840","article-title":"High levels of cathepsin S and cystatin C in patients with fibromyalgia syndrome","volume":"23","author":"Kocak","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib186","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1246\/bcsj.20210099","article-title":"Development of off-on switching 19F MRI probes for cathepsin K activity detection","volume":"94","author":"Konishi","year":"2021","journal-title":"Bull. Chem. Soc. Jpn."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib187","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.10185","article-title":"Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis","volume":"46","author":"Konttinen","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mam.2022.101150_bib188","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","article-title":"Therapeutic targeting of cathepsin C: from pathophysiology to treatment","volume":"190","author":"Korkmaz","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib189","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/172460080001500116","article-title":"Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer","volume":"15","author":"Kos","year":"2000","journal-title":"Int. J. Biol. Markers"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0014-5793(99)00897-2","article-title":"Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases","volume":"455","author":"Kostoulas","year":"1999","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib191","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jor.23005","article-title":"Increased expression and activation of cathepsin K in human osteoarthritic cartilage and synovial tissues","volume":"34","author":"Kozawa","year":"2016","journal-title":"J. Orthop. Res."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib192","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.33398","article-title":"Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis","volume":"64","author":"Kozawa","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib193","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.7150\/thno.19081","article-title":"Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin","volume":"7","author":"Kramer","year":"2017","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib194","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tips.2017.06.003","article-title":"The future of cysteine cathepsins in disease management","volume":"38","author":"Kramer","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ncb2171","article-title":"Stat3 controls lysosomal-mediated cell death in vivo","volume":"13","author":"Kreuzaler","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib196","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/path.2485","article-title":"Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages","volume":"217","author":"Krueger","year":"2009","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib197","first-page":"38","article-title":"Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma","volume":"51","author":"Kruszewski","year":"2004","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib198","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/infdis\/jiv458","article-title":"Cathepsin K contributes to cavitation and collagen turnover in pulmonary tuberculosis","volume":"213","author":"Kubler","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib199","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12018-011-9096-4","article-title":"Cathepsins S, L, and K and their pathophysiological relevance in obesity","volume":"9","author":"Lafarge","year":"2011","journal-title":"Clin. Rev. Bone Miner. Metabol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02907801","article-title":"The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease","volume":"3","author":"Lah","year":"1997","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib201","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.joca.2003.11.005","article-title":"Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes","volume":"12","author":"Lai","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/hsz-2014-0210","article-title":"Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases","volume":"396","author":"Lalmanach","year":"2015","journal-title":"Biol. Chem."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib203","first-page":"1970","article-title":"The relative importance of cysteine peptidases in osteoarthritis","volume":"27","author":"Lang","year":"2000","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib204","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biochi.2007.08.011","article-title":"Biochemical properties and regulation of cathepsin K activity","volume":"90","author":"Lecaille","year":"2008","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib205","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.biocel.2013.05.018","article-title":"Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties","volume":"45","author":"Lecaille","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib206","article-title":"Overexpression of cathepsin S exacerbates lupus pathogenesis through upregulation TLR7 and IFN-alpha in transgenic mice","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090876","article-title":"Cathepsin B-responsive liposomes for controlled anticancer drug delivery in hep G2 cells","volume":"12","author":"Lee","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7578","key":"10.1016\/j.mam.2022.101150_bib208","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib209","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1172\/JCI15555","article-title":"Decreased atherosclerosis in CX3CR1-\/- mice reveals a role for fractalkine in atherogenesis","volume":"111","author":"Lesnik","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib437","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2008.03.027","article-title":"Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis","volume":"202","author":"Li","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib211","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3349\/ymj.2014.55.4.912","article-title":"Increased serum cathepsin K in patients with coronary artery disease","volume":"55","author":"Li","year":"2014","journal-title":"Yonsei Med. J."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib212","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.cclet.2020.05.027","article-title":"Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors","volume":"31","author":"Li","year":"2020","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib213","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M310349200","article-title":"Regulation of collagenase activities of human cathepsins by glycosaminoglycans","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib214","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12915-019-0719-4","article-title":"Peripheral cathepsin L inhibition induces fat loss in C. elegans and mice through promoting central serotonin synthesis","volume":"17","author":"Lin","year":"2019","journal-title":"BMC Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12967-018-1425-7","article-title":"The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis","volume":"16","author":"Lindstrom","year":"2018","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib216","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1515\/BC.2006.160","article-title":"Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins","volume":"387","author":"Linke","year":"2006","journal-title":"Biol. Chem."},{"issue":"Pt 24","key":"10.1016\/j.mam.2022.101150_bib217","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1242\/jcs.00184","article-title":"Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal\/lysosomal compartment","volume":"115","author":"Linke","year":"2002","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib218","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib219","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.0000134530.27208.41","article-title":"Lysosomal cysteine proteases in atherosclerosis","volume":"24","author":"Liu","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF03402068","article-title":"Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions","volume":"5","author":"Liuzzo","year":"1999","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib221","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib222","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1000436","article-title":"P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases","volume":"185","author":"Lopez-Castejon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2022.101150_bib223","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fchem.2015.00037","article-title":"Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes","volume":"3","author":"Loser","year":"2015","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib224","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","article-title":"Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation","volume":"113","author":"Lutgens","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib225","doi-asserted-by":"crossref","first-page":"G894","DOI":"10.1152\/ajpgi.00073.2012","article-title":"Active cathepsins B, L, and S in murine and human pancreatitis","volume":"303","author":"Lyo","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib226","article-title":"MPI8 is potent against SARS-CoV-2 by inhibiting dually and selectively the SARS-CoV-2 main protease and the host cathepsin L","volume":"17","author":"Ma","year":"2022","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib227","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1172\/JCI25485","article-title":"Cathepsin L is essential for onset of autoimmune diabetes in NOD mice","volume":"115","author":"Maehr","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.mam.2022.101150_bib228","doi-asserted-by":"crossref","first-page":"12806","DOI":"10.1074\/jbc.275.17.12806","article-title":"Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells","volume":"275","author":"Mai","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib229","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41589-019-0271-0","article-title":"Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme","volume":"15","author":"Maianti","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib230","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1080\/15548627.2016.1239679","article-title":"Regulation of lysosomal dynamics and autophagy by CTSB\/cathepsin B","volume":"12","author":"Man","year":"2016","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib231","first-page":"3340","article-title":"Impaired autophagic flux mediates acinar cell vacuole formation and trypsinogen activation in rodent models of acute pancreatitis","volume":"119","author":"Mareninova","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib232","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2016.12.008","article-title":"Antibody-antibiotic conjugates: a novel therapeutic platform against bacterial infections","volume":"23","author":"Mariathasan","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib233","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/wound.2012.0370","article-title":"Proteases and delayed wound healing","volume":"2","author":"McCarty","year":"2013","journal-title":"Adv. Wound Care"},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib234","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study","volume":"7","author":"McClung","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2990.1993.tb00420.x","article-title":"Secretion of cathepsin B by human gliomas in vitro","volume":"19","author":"McCormick","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib236","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.joca.2010.07.014","article-title":"Cathepsin K inhibition reduces CTXII levels and joint pain in the Guinea pig model of spontaneous osteoarthritis","volume":"18","author":"McDougall","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib237","article-title":"Update on drug development targeting parasite cysteine proteases","volume":"12","author":"McKerrow","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mam.2022.101150_bib238","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3389\/fonc.2019.01239","article-title":"Expression and clinical implications of cysteine cathepsins in gallbladder carcinoma","volume":"9","author":"Mehra","year":"2019","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.mam.2022.101150_bib239","first-page":"1","article-title":"Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease","volume":"52","author":"Meier","year":"2006","journal-title":"Clin. Lab."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib240","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acschembio.0c00875","article-title":"A clinical-stage cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells","volume":"16","author":"Mellott","year":"2021","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib241","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12903-018-0518-2","article-title":"Role of cathepsin S In periodontal wound healing-an in vitro study on human PDL cells","volume":"18","author":"Memmert","year":"2018","journal-title":"BMC Oral Health"},{"issue":"38","key":"10.1016\/j.mam.2022.101150_bib242","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1002\/ange.201402305","article-title":"Selective targeting of tumor and stromal cells by a nanocarrier system displaying lipidated cathepsin B inhibitor","volume":"126","author":"Mikhaylov","year":"2014","journal-title":"Angew. Chem."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib243","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/bcp.13398","article-title":"Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)","volume":"83","author":"Miller","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib244","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.13144","article-title":"Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus","volume":"159","author":"Mo","year":"2020","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab deruxtecan in previously treated HER2-positive breast cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib246","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc1949","article-title":"Cysteine cathepsins: multifunctional enzymes in cancer","volume":"6","author":"Mohamed","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mam.2022.101150_bib247","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbi.2019.10.018","article-title":"Changes in vascular permeability in the spinal cord contribute to chemotherapy-induced neuropathic pain","volume":"83","author":"Montague-Cardoso","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib248","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cmet.2016.05.025","article-title":"Running-induced systemic cathepsin B secretion is associated with memory function","volume":"24","author":"Moon","year":"2016","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib249","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081806","article-title":"A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-alzheimer's disease and MCI patients: implications for regenerative medicine approaches","volume":"18","author":"Morena","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib251","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/art.21423","article-title":"Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K","volume":"52","author":"Morko","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib252","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ard.2002.004671","article-title":"Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis","volume":"63","author":"Morko","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib253","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.joca.2016.03.016","article-title":"Early cathepsin K degradation of type II collagen in vitro and in vivo in articular cartilage","volume":"24","author":"Mort","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"issue":"Pt 3","key":"10.1016\/j.mam.2022.101150_bib254","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/bj3350491","article-title":"Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope","volume":"335","author":"Mort","year":"1998","journal-title":"Biochem. J."},{"issue":"9980","key":"10.1016\/j.mam.2022.101150_bib255","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)60165-9","article-title":"Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"385","author":"Moskowitz","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib256","first-page":"1044","article-title":"Chronic fatigue syndrome: what is it and how to treat? The lancet","volume":"2","author":"Moylan","year":"2015","journal-title":"Psychiatry"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib257","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acschembio.1c00753","article-title":"Activity-based diagnostics: recent advances in the development of probes for use with diverse detection modalities","volume":"17","author":"Muir","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib258","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.maturitas.2009.09.011","article-title":"Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate","volume":"64","author":"Munoz-Torres","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib259","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(02)00018-7","article-title":"pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque","volume":"164","author":"Naghavi","year":"2002","journal-title":"Atherosclerosis"},{"issue":"41","key":"10.1016\/j.mam.2022.101150_bib260","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1021\/bi971264+","article-title":"Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts","volume":"36","author":"Nagler","year":"1997","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib261","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1074-7613(00)80021-7","article-title":"Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice","volume":"10","author":"Nakagawa","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib262","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/1673-5374.264444","article-title":"Microglial cathepsin B as a key driver of inflammatory brain diseases and brain aging","volume":"15","author":"Nakanishi","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib263","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/exnr.1994.1048","article-title":"Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues","volume":"126","author":"Nakanishi","year":"1994","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib264","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.abb.2005.01.013","article-title":"Cathepsin X binds to cell surface heparan sulfate proteoglycans","volume":"436","author":"Nascimento","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacep.2017.03.002","article-title":"Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation","volume":"3","author":"Nattel","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"issue":"22","key":"10.1016\/j.mam.2022.101150_bib266","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.mam.2022.101150_bib267","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1038\/onc.2008.144","article-title":"Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels","volume":"27","author":"Navab","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib268","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10072-012-1022-0","article-title":"Cerebrospinal fluid cathepsin B and S","volume":"34","author":"Nilsson","year":"2013","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib269","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00280-019-03875-6","article-title":"Moxetumomab pasudotox-tdfk for relapsed\/refractory hairy cell leukemia: a review of clinical considerations","volume":"84","author":"Nobre","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mam.2022.101150_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-1","article-title":"Cathepsin B: a potential prognostic marker for inflammatory breast cancer","volume":"9","author":"Nouh","year":"2011","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106642","article-title":"Probing the activity modification space of the cysteine peptidase cathepsin K with novel allosteric modifiers","volume":"9","author":"Novinec","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib272","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.joca.2017.01.002","article-title":"Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA","volume":"25","author":"Nwosu","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib273","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1097\/PR9.0000000000000685","article-title":"Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain","volume":"3","author":"Nwosu","year":"2018","journal-title":"Pain Rep."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib274","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejcb.2009.03.003","article-title":"Cathepsin X prevents an effective immune response against Helicobacter pylori infection","volume":"88","author":"Obermajer","year":"2009","journal-title":"Eur. J. Cell Biol."},{"issue":"13","key":"10.1016\/j.mam.2022.101150_bib275","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.yexcr.2006.04.019","article-title":"Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells","volume":"312","author":"Obermajer","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib276","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1189\/jlb.0508285","article-title":"Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X","volume":"84","author":"Obermajer","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib277","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcsm.12248","article-title":"Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice","volume":"9","author":"Ogasawara","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"20","key":"10.1016\/j.mam.2022.101150_bib278","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","article-title":"DS-8201a, A novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1","volume":"22","author":"Ogitani","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib279","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response","volume":"15","author":"Olson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib280","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib281","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1073\/pnas.0606091104","article-title":"Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms","volume":"104","author":"Pagano","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.mam.2022.101150_bib282","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/jm00017a002","article-title":"Vinyl sulfones as mechanism-based cysteine protease inhibitors","volume":"38","author":"Palmer","year":"1995","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib283","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s10120-020-01080-6","article-title":"Cathepsin L promotes angiogenesis by regulating the CDP\/Cux\/VEGF-D pathway in human gastric cancer","volume":"23","author":"Pan","year":"2020","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib284","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bph.14133","article-title":"Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone","volume":"175","author":"Panwar","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib285","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jbmr.3227","article-title":"An ectosteric inhibitor of cathepsin K inhibits bone resorption in ovariectomized mice","volume":"32","author":"Panwar","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib286","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/bcp.12470","article-title":"Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects","volume":"78","author":"Payne","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib287","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02588-18","article-title":"A phase 1, randomized, single-ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus thiomab antibody-antibiotic conjugate, in healthy volunteers","volume":"63","author":"Peck","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib288","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41574-019-0174-x","article-title":"Physical activity and muscle-brain crosstalk","volume":"15","author":"Pedersen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib289","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bone.2003.11.021","article-title":"The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K","volume":"34","author":"Pelletier","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2008.08.130","article-title":"Bone density, strength, and formation in adult cathepsin K (-\/-) mice","volume":"44","author":"Pennypacker","year":"2009","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib291","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbadis.2005.10.005","article-title":"Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids","volume":"1762","author":"Perdereau","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2022.101150_bib292","doi-asserted-by":"crossref","DOI":"10.1038\/srep32247","article-title":"Role of cathepsins in Mycobacterium tuberculosis survival in human macrophages","volume":"6","author":"Pires","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib293","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4155\/fmc.09.4","article-title":"Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?","volume":"1","author":"Podgorski","year":"2009","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib294","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/febs.15227","article-title":"Protease-activated prodrugs: strategies, challenges, and future directions","volume":"287","author":"Poreba","year":"2020","journal-title":"FEBS J."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib295","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib296","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/bc.2010.035","article-title":"Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis","volume":"391","author":"Pozgan","year":"2010","journal-title":"Biol. Chem."},{"issue":"18","key":"10.1016\/j.mam.2022.101150_bib297","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"42","key":"10.1016\/j.mam.2022.101150_bib298","first-page":"4816","article-title":"Nanoparticle based delivery of protease inhibitors to cancer cells","volume":"24","author":"Prunk","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib299","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.20151938","article-title":"Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection","volume":"213","author":"Qi","year":"2016","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cvr\/cvs263","article-title":"Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice","volume":"96","author":"Qin","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"D1","key":"10.1016\/j.mam.2022.101150_bib301","doi-asserted-by":"crossref","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","article-title":"The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database","volume":"46","author":"Rawlings","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mam.2022.101150_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108121","article-title":"Interplay between tetrameric structure, enzymatic activity and allosteric regulation of human dipeptidyl-peptidase I","volume":"675","author":"Rebernik","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib303","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/jid.2009.430","article-title":"Cathepsin S elicits itch and signals via protease-activated receptors","volume":"130","author":"Reddy","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mam.2022.101150_bib304","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1038\/ncomms8864","article-title":"Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs","volume":"6","author":"Reddy","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028029","article-title":"Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS One"},{"issue":"Pt 3","key":"10.1016\/j.mam.2022.101150_bib306","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/bj3190793","article-title":"Expression of functional recombinant human procathepsin B in mammalian cells","volume":"319","author":"Ren","year":"1996","journal-title":"Biochem. J."},{"issue":"22","key":"10.1016\/j.mam.2022.101150_bib307","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1074\/jbc.M115.638395","article-title":"Cysteine cathepsins activate ELR chemokines and inactivate non-ELR chemokines","volume":"290","author":"Repnik","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib308","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/mabs.22854","article-title":"Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates","volume":"5","author":"Ritchie","year":"2013","journal-title":"mAbs"},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib309","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.2016.2240","article-title":"Biomarkers and surrogate endpoints: developing common terminology and definitions","volume":"315","author":"Robb","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib310","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.ATV.0000203526.75772.4b","article-title":"Destabilizing role of cathepsin S in murine atherosclerotic plaques","volume":"26","author":"Rodgers","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.mam.2022.101150_bib311","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/0008-5472.CAN-06-0983","article-title":"Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice","volume":"66","author":"Rofstad","year":"2006","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.mam.2022.101150_bib312","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1200\/JCO.19.01140","article-title":"Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1\/programmed death ligand 1 therapy","volume":"37","author":"Rosenberg","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.mam.2022.101150_bib313","first-page":"6517","article-title":"Pericellular pH affects distribution and secretion of cathepsin B in malignant cells","volume":"54","author":"Rozhin","year":"1994","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.mam.2022.101150_bib314","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1101\/gad.224899.113","article-title":"Cathepsin C is a tissue-specific regulator of squamous carcinogenesis","volume":"27","author":"Ruffell","year":"2013","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/annrheumdis-2013-203717","article-title":"Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming","volume":"74","author":"Rupanagudi","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib316","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaad.2020.06.036","article-title":"Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis","volume":"84","author":"Saag","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"23","key":"10.1016\/j.mam.2022.101150_bib317","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2022.101150_bib436","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2011.12.027","article-title":"Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B\/L mediated generation of neuroprotective perlecan LG3 by neurons","volume":"1438","author":"Saini","year":"2012","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib318","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/138945007779940188","article-title":"Role of cathepsin K in normal joints and in the development of arthritis","volume":"8","author":"Salminen-Mankonen","year":"2007","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib319","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0016-5085(97)70108-2","article-title":"Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B","volume":"113","author":"Saluja","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/FJC.0b013e3181e23e10","article-title":"Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-\/- mice","volume":"56","author":"Samokhin","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib321","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2007.12.047","article-title":"Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice","volume":"200","author":"Samokhin","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mam.2022.101150_bib322","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-biochem-060713-035352","article-title":"Activity-based profiling of proteases","volume":"83","author":"Sanman","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mam.2022.101150_bib323","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.752105","article-title":"P2X7 receptor triggers lysosomal leakage through calcium mobilization in a mechanism dependent on pannexin-1 hemichannels","volume":"13","author":"Santos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2022.101150_bib324","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biomaterials.2015.03.039","article-title":"Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy","volume":"59","author":"Satsangi","year":"2015","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib325","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/mp500128k","article-title":"Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells","volume":"11","author":"Satsangi","year":"2014","journal-title":"Mol. Pharm."},{"issue":"28","key":"10.1016\/j.mam.2022.101150_bib326","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1039\/D1OB00225B","article-title":"Molecular probes for selective detection of cysteine cathepsins","volume":"19","author":"Schleyer","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.mam.2022.101150_bib327","series-title":"Innovative Rheumatology","first-page":"287","article-title":"Role of cysteine cathepsins in joint inflammation and destruction in human rheumatoid arthritis and associated animal models","author":"Schurigt","year":"2013"},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib328","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00011-012-0495-x","article-title":"Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment","volume":"61","author":"Schurigt","year":"2012","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib329","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/172460080401900406","article-title":"Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer","volume":"19","author":"Schweiger","year":"2004","journal-title":"Int. J. Biol. Markers"},{"issue":"13","key":"10.1016\/j.mam.2022.101150_bib330","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.7150\/thno.31037","article-title":"Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions","volume":"9","author":"Schwenck","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib331","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.19.00172","article-title":"Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma","volume":"38","author":"Sehn","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mam.2022.101150_bib431","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2017.00088","article-title":"Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease","volume":"4","author":"Sena","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"issue":"28","key":"10.1016\/j.mam.2022.101150_bib332","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1074\/jbc.M116.718999","article-title":"Cathepsin B activity initiates apoptosis via digestive protease activation in pancreatic acinar cells and experimental pancreatitis","volume":"291","author":"Sendler","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib333","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2017.10.018","article-title":"Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice","volume":"154","author":"Sendler","year":"2018","journal-title":"Gastroenterology"},{"issue":"6036","key":"10.1016\/j.mam.2022.101150_bib334","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib335","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ncb3011","article-title":"Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S","volume":"16","author":"Sevenich","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib336","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20140809","article-title":"Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor","volume":"465","author":"Sharma","year":"2015","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib337","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1074-7613(00)80020-5","article-title":"Cathepsin S required for normal MHC class II peptide loading and germinal center development","volume":"10","author":"Shi","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib338","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01387-16","article-title":"Clinical isolates of human coronavirus 229E bypass the endosome for cell entry","volume":"91","author":"Shirato","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2022.101150_bib339","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2017.11.012","article-title":"Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry","volume":"517","author":"Shirato","year":"2018","journal-title":"Virology"},{"issue":"23","key":"10.1016\/j.mam.2022.101150_bib340","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.180331.111","article-title":"Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer","volume":"25","author":"Shree","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.mam.2022.101150_bib341","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.mam.2022.101150_bib342","article-title":"Fractalkine\/CX3CR1 pathway in neuropathic pain: an update","volume":"35","author":"Silva","year":"2021","journal-title":"Front. Pain Res."},{"issue":"33","key":"10.1016\/j.mam.2022.101150_bib343","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib344","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2478\/raon-2013-0043","article-title":"Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori","volume":"47","author":"Skvarc","year":"2013","journal-title":"Radiol. Oncol."},{"issue":"4499","key":"10.1016\/j.mam.2022.101150_bib345","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.7233209","article-title":"Lysosomal cathepsin B: correlation with metastatic potential","volume":"212","author":"Sloane","year":"1981","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib346","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01523-2018","article-title":"Targeting of cathepsin S reduces cystic fibrosis-like lung disease","volume":"53","author":"Small","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib347","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12018-011-9095-5","article-title":"The emerging relevance of the cysteine protease cathepsin S in disease","volume":"9","author":"Small","year":"2011","journal-title":"Clin. Rev. Bone Miner. Metabol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib348","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10549-018-4845-4","article-title":"Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system","volume":"171","author":"Smith","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib349","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/hmg\/dds558","article-title":"Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis","volume":"22","author":"Smith","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib433","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.111.187807","article-title":"Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease","volume":"59","author":"Smith","year":"2012","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib350","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1074\/mcp.M114.044628","article-title":"Proteomic identification of cysteine cathepsin substrates shed from the surface of cancer cells","volume":"14","author":"Sobotic","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2022.101150_bib351","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1465-9921-9-54","article-title":"Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis","volume":"9","author":"Srivastava","year":"2008","journal-title":"Respir. Res."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib352","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nchem.2635","article-title":"Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates","volume":"8","author":"Staben","year":"2016","journal-title":"Nat. Chem."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib353","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.exphem.2008.10.011","article-title":"Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs","volume":"37","author":"Stoeckle","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.mam.2022.101150_bib354","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","article-title":"Lysosomal cathepsins and their regulation in aging and neurodegeneration","volume":"32","author":"Stoka","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib355","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10585-016-9790-1","article-title":"Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94","volume":"33","author":"Sudhan","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib356","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI181","article-title":"Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells","volume":"102","author":"Sukhova","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib357","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI200314915","article-title":"Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice","volume":"111","author":"Sukhova","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib358","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/ATVBAHA.111.235002","article-title":"Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice","volume":"32","author":"Sun","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib359","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1161\/ATVBAHA.111.230201","article-title":"Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice","volume":"31","author":"Sun","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib360","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/cvr\/cvq328","article-title":"Cathepsin-L contributes to cardiac repair and remodelling post-infarction","volume":"89","author":"Sun","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib361","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-2010-101023","article-title":"Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls","volume":"22","author":"Sundelof","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib362","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13550-020-00688-0","article-title":"Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model","volume":"10","author":"Suurs","year":"2020","journal-title":"EJNMMI Res."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib363","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01200-2015","article-title":"Protean proteases: at the cutting edge of lung diseases","volume":"49","author":"Taggart","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib364","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1210\/en.2006-0386","article-title":"Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation","volume":"147","author":"Taleb","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib365","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.gastro.2016.06.042","article-title":"Release of cathepsin B in cytosol causes cell death in acute pancreatitis","volume":"151","author":"Talukdar","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib366","doi-asserted-by":"crossref","DOI":"10.3390\/membranes10120406","article-title":"Lysosomal exocytosis: the extracellular role of an intracellular organelle","volume":"10","author":"Tancini","year":"2020","journal-title":"Membranes"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib367","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1038\/s41598-017-01894-y","article-title":"Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury","volume":"7","author":"Tato","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2022.101150_bib368","series-title":"THE PERIPHERAL BLOOD OF OSTEOARTHRITIC PATIENTS PRIOR TO SURGERY AS A BIOMARKER OF POST-OPERATIVE PAIN DEVELOPMENT","article-title":"THU0472 cathepsin S gene expression measured","author":"Tchetina","year":"2020"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib369","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrmicro2508","article-title":"Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?","volume":"9","author":"Thwaites","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib430","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s13104-017-2940-y","article-title":"Extracellular cathepsin L stimulates axonal growth in neurons","volume":"10","author":"Tohda","year":"2017","journal-title":"BMC Res. Notes."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib370","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI200318028","article-title":"Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis","volume":"112","author":"Tolosa","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"19","key":"10.1016\/j.mam.2022.101150_bib371","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195847","article-title":"An insight into FDA approved antibody-drug conjugates for cancer therapy","volume":"26","author":"Tong","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib372","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/70525","article-title":"Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis","volume":"23","author":"Toomes","year":"1999","journal-title":"Nat. Genet."},{"issue":"23","key":"10.1016\/j.mam.2022.101150_bib429","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1523\/JNEUROSCI.3214-17.2018","article-title":"Modulation of receptor protein tyrosine phosphatase sigma increases chondroitin sulfate proteoglycan degradation through cathepsin B secretion to enhance axon outgrowth","volume":"38","author":"Tran","year":"2018","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib373","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib374","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/dnp.2004.17.1.829022","article-title":"The role of cathepsin K in normal bone resorption","volume":"17","author":"Troen","year":"2004","journal-title":"Drug News Perspect."},{"issue":"38","key":"10.1016\/j.mam.2022.101150_bib375","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1021\/jacs.8b05817","article-title":"CT imaging of enzymatic activity in cancer using covalent probes reveal a size-dependent pattern","volume":"140","author":"Tsvirkun","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"18","key":"10.1016\/j.mam.2022.101150_bib376","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184697","article-title":"Cathepsin S evokes PAR2-dependent pain in oral squamous cell carcinoma patients and preclinical mouse models","volume":"13","author":"Tu","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib377","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","article-title":"Targeting proteases: successes, failures and future prospects","volume":"5","author":"Turk","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib378","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib379","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.febslet.2004.12.093","article-title":"Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans","volume":"579","author":"Vasiljeva","year":"2005","journal-title":"FEBS Lett."},{"issue":"46","key":"10.1016\/j.mam.2022.101150_bib380","doi-asserted-by":"crossref","first-page":"13522","DOI":"10.1021\/bi035355k","article-title":"Recombinant human cathepsin H lacking the mini chain is an endopeptidase","volume":"42","author":"Vasiljeva","year":"2003","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib381","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/0008-5472.CAN-05-4463","article-title":"Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer","volume":"66","author":"Vasiljeva","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mam.2022.101150_bib382","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/138161207780162962","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib383","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030264","article-title":"Cysteine cathepsins and their extracellular roles: shaping the microenvironment","volume":"8","author":"Vidak","year":"2019","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.mam.2022.101150_bib384","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.15252\/embj.201796750","article-title":"Protease cleavage site fingerprinting by label-free in-gel degradomics reveals pH-dependent specificity switch of legumain","volume":"36","author":"Vidmar","year":"2017","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib385","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.humimm.2007.05.009","article-title":"Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis","volume":"68","author":"Viken","year":"2007","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib386","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.joca.2008.07.017","article-title":"Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis","volume":"17","author":"Vinardell","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib387","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2478\/v10019-012-0040-0","article-title":"Cathepsin X in serum from patients with colorectal cancer: relation to prognosis","volume":"46","author":"Vizin","year":"2012","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.mam.2022.101150_bib388","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.matbio.2018.01.024","article-title":"Cysteine cathepsins in extracellular matrix remodeling: extracellular matrix degradation and beyond","volume":"75\u201376","author":"Vizovisek","year":"2019","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib389","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/14728222.2020.1746765","article-title":"Cysteine cathepsins as therapeutic targets in inflammatory diseases","volume":"24","author":"Vizovisek","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib390","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tibs.2018.07.003","article-title":"Protease specificity: towards in vivo imaging applications and biomarker discovery","volume":"43","author":"Vizovisek","year":"2018","journal-title":"Trends Biochem. Sci."},{"issue":"14","key":"10.1016\/j.mam.2022.101150_bib391","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/pmic.201400460","article-title":"Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S","volume":"15","author":"Vizovisek","year":"2015","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.mam.2022.101150_bib392","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1074\/jbc.M509134200","article-title":"Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6218","key":"10.1016\/j.mam.2022.101150_bib393","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1257132","article-title":"Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1","volume":"347","author":"Wang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mam.2022.101150_bib394","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide-drug conjugates as effective prodrug strategies for targeted delivery","volume":"110\u2013111","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2022.101150_bib395","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2020.02.013","article-title":"Oxidation of cathepsin S by major chemicals of cigarette smoke","volume":"150","author":"Wartenberg","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib396","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2009.10.048","article-title":"Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice","volume":"138","author":"Wartmann","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib435","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/febs.14043","article-title":"Cysteine proteases in atherosclerosis","volume":"284","author":"Weiss-Sadan","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.mam.2022.101150_bib397","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2008.07.067","article-title":"Upregulation of cathepsin S in the aging and pathological nervous system of mice","volume":"1232","author":"Wendt","year":"2008","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib398","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.expneurol.2007.01.007","article-title":"Differential expression of cathepsin X in aging and pathological central nervous system of mice","volume":"204","author":"Wendt","year":"2007","journal-title":"Exp. Neurol."},{"issue":"320","key":"10.1016\/j.mam.2022.101150_bib399","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0293","article-title":"A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer","volume":"8","author":"Whitley","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib400","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41551-020-00616-6","article-title":"AND-gate contrast agents for enhanced fluorescence-guided surgery","volume":"5","author":"Widen","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib401","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jamasurg.2014.926","article-title":"Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010","volume":"149","author":"Wilke","year":"2014","journal-title":"JAMA Surg."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib402","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1515\/hsz-2015-0114","article-title":"Cathepsin S: therapeutic, diagnostic, and prognostic potential","volume":"396","author":"Wilkinson","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.mam.2022.101150_bib403","series-title":"\u00dcber die Proteasen der Magenschleimhaut. Erste Abhandlung \u00fcber die Enzyme der Leukocyten","author":"Willst\u00e4tter","year":"1929"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib404","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities","volume":"175","author":"Wilson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mam.2022.101150_bib405","doi-asserted-by":"crossref","DOI":"10.1038\/srep19755","article-title":"Non-invasive imaging of idiopathic pulmonary fibrosis using cathepsin protease probes","volume":"6","author":"Withana","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2022.101150_bib406","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biochi.2015.11.003","article-title":"In vivo imaging of protease activity by Probody therapeutic activation","volume":"122","author":"Wong","year":"2016","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib407","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5551\/jat.RV17016","article-title":"Cysteine protease cathepsins in atherosclerotic cardiovascular diseases","volume":"25","author":"Wu","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib408","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1210\/jc.2005-2486","article-title":"Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity","volume":"91","author":"Xiao","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mam.2022.101150_bib409","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/187873","article-title":"Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice","volume":"2013","author":"Xu","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.mam.2022.101150_bib410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-6-20","article-title":"Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011","volume":"6","author":"Xue","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib411","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.addr.2012.11.006","article-title":"Pharmacokinetic considerations for targeted drug delivery","volume":"65","author":"Yamashita","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.mam.2022.101150_bib412","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.celrep.2016.08.035","article-title":"STAT3 and STAT6 signaling pathways synergize to promote cathepsin secretion from macrophages via IRE1alpha activation","volume":"16","author":"Yan","year":"2016","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.mam.2022.101150_bib413","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/sj.onc.1207338","article-title":"Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis","volume":"23","author":"Yanamandra","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib414","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/acs.molpharmaceut.6b01005","article-title":"Backbone degradable N-(2-Hydroxypropyl)methacrylamide copolymer conjugates with gemcitabine and paclitaxel: impact of molecular weight on activity toward human ovarian carcinoma xenografts","volume":"14","author":"Yang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib415","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/med.21720","article-title":"Making smart drugs smarter: the importance of linker chemistry in targeted drug delivery","volume":"40","author":"Yang","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.mam.2022.101150_bib416","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.addr.2004.12.013","article-title":"The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics","volume":"57","author":"Yasuda","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"35","key":"10.1016\/j.mam.2022.101150_bib432","doi-asserted-by":"crossref","first-page":"36761","DOI":"10.1074\/jbc.M403986200","article-title":"Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages","volume":"279","author":"Yasuda","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.mam.2022.101150_bib417","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ajpath.2012.08.027","article-title":"TGF-beta signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells","volume":"181","author":"Yin","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mam.2022.101150_bib418","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103417","article-title":"A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis","volume":"94","author":"Yuan","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.mam.2022.101150_bib419","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/HYPERTENSIONAHA.122.19137","article-title":"Cathepsin K deficiency prevented kidney damage and dysfunction in response to 5\/6 nephrectomy injury in mice with or without chronic stress","volume":"79","author":"Yue","year":"2022","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/acsptsci.9b00035","article-title":"Cathepsin B dependent cleavage product of serum amyloid A1 identifies patients with chemotherapy-related cardiotoxicity","volume":"2","author":"Zhang","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.mam.2022.101150_bib421","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2005-7205","article-title":"Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease","volume":"7","author":"Zhang","year":"2005","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.mam.2022.101150_bib422","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3892\/mmr.2014.2706","article-title":"Cathepsin L is involved in proliferation and invasion of ovarian cancer cells","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib423","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2967\/jnumed.119.231282","article-title":"Development of improved tumor-residualizing, GRPR-targeted agents: preclinical comparison of an endolysosomal trapping approach in agonistic and antagonistic constructs","volume":"61","author":"Zhang","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.mam.2022.101150_bib424","first-page":"3423","article-title":"Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis","volume":"31","author":"Zhang","year":"2011","journal-title":"Anticancer Res."},{"issue":"39","key":"10.1016\/j.mam.2022.101150_bib425","doi-asserted-by":"crossref","first-page":"27215","DOI":"10.1074\/jbc.M114.599712","article-title":"Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mam.2022.101150_bib426","doi-asserted-by":"crossref","DOI":"10.1038\/am.2017.42","article-title":"Peptide-mediated core\/satellite\/shell multifunctional nanovehicles for precise imaging of cathepsin B activity and dual-enzyme controlled drug release","volume":"9","author":"Zheng","year":"2017","journal-title":"NPG Asia Mater."},{"issue":"17","key":"10.1016\/j.mam.2022.101150_bib427","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome\/lysosome and block the entry of Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mam.2022.101150_bib428","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.4049\/jimmunol.1501145","article-title":"Cathepsin K deficiency ameliorates systemic lupus erythematosus-like manifestations in fas(lpr) mice","volume":"198","author":"Zhou","year":"2017","journal-title":"J. Immunol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299722000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299722000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:20:35Z","timestamp":1758824435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299722000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":436,"alternative-id":["S0098299722000954"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2022.101150","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cysteine cathepsins: A long and winding road towards clinics","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2022.101150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101150"}}